Virax Biolabs Group Limited Ordinary Shares (VRAX) — Defensive Interval Ratio
Virax Biolabs Group Limited Ordinary Shares (VRAX) has a Defensive Interval Ratio of 175 days as of September 2025. Defensive assets of $175.70K (cash $-, short-term investments $-, receivables $175.70K) cover 175 days of daily cash needs of $1.00K/day. Check Virax Biolabs Group Limited Ordinary Sha tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Virax Biolabs Group Limited Ordinary Shares Defensive Interval Ratio (2020–2025)
This chart shows how Virax Biolabs Group Limited Ordinary Shares's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of September 2025, the ratio stands at 175 days, meaning defensive assets of $175.70K can fund 175 days of operations without new revenue. Also explore how fast is Virax Biolabs Group Limited Ordinary Sha growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Virax Biolabs Group Limited Ordinary Shares (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Virax Biolabs Group Limited Ordinary Shares from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see VRAX market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 68 days | $124.84K | $1.84K/day | $- | $94.19K | ▼ -570 days |
| 2024 | 638 days | $295.16K | $462.60/day | $- | $77.32K | ▲ +628 days |
| 2023 | 10 days | $25.16K | $2.49K/day | $- | $49.26K | ▲ +8 days |
| 2022 | 2 days | $6.00K | $3.41K/day | $- | $6.00K | ▲ +1 days |
| 2021 | 0 days | $928.00 | $2.39K/day | $- | $- | ▲ +0 days |
| 2020 | 0 days | $0.00 | $3.39K/day | $- | $- | — |